Strong evidence that anti-pdgfr antibodies cause scleroderma

Access through your institution Buy or subscribe Baroni SS _ et al_. (2006) Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. _N Engl J Med_ 354: 2667–2676 A rigorous,

international study published in the _New England Journal of Medicine_ has demonstrated the presence of IgG autoantibodies that stimulate the fibroblast receptor for platelet-derived growth

factor (PDGFR-stimulatory antibodies) in sera from patients with systemic sclerosis (scleroderma). This is a preview of subscription content, access via your institution ACCESS OPTIONS

Access through your institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on

SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about

institutional subscriptions * Read our FAQs * Contact customer support RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Strong evidence that anti-PDGFR

antibodies cause scleroderma. _Nat Rev Rheumatol_ 2, 522 (2006). https://doi.org/10.1038/ncprheum0278 Download citation * Issue Date: October 2006 * DOI: https://doi.org/10.1038/ncprheum0278

SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy

to clipboard Provided by the Springer Nature SharedIt content-sharing initiative